New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers
新型联合方案与氟达拉滨、阿糖胞苷和伊达比星治疗中低危核仁磷蛋白-1突变急性髓系白血病的疗效比较:来自7个意大利中心的回顾性分析
期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14030700
Battaglia, Giulia; Lazzarotto, Davide; Tanasi, Ilaria; Gurrieri, Carmela; Forlani, Laura; Mauro, Endri; Capraro, Francesca; Ciotti, Giulia; De Bellis, Eleonora; Callegari, Chiara; Tosoni, Luca; Fanin, Matteo; Morelli, Gian Luca; Simio, Claudia; Skert, Cristina; Gottardi, Michele; Zaja, Francesco; Toffoletti, Eleonora; Damiani, Daniela; Fanin, Renato; Tiribelli, Mario